Organization | University of Limerick

University of Limerick Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Limerick Ireland (1972)

Organization Overview

First Clinical Trial

2008

NCT01347814

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

UL Hospitals | UL Hospitals, Limerick | Univeristy of Limerick | University of Limerick

Active Ingredients

Drugs in Phase 4 Trials (3)

elexacaftor (Trifakta) (1 trial)

ivacaftor (Kalydeco) (1 trial)

tezacaftor (Trifakta) (1 trial)

Drugs in Phase 3 Trials (1)

colchicine (colbenemid) (1 trial)

Drugs in Other Trials (14)

amino acids (Freamine) (2 trials)

arginine (1 trial)

chickpea protein (1 trial)

cinnamon (1 trial)

domperidone (1 trial)

fava beans (1 trial)

lentil (1 trial)

macadamia oil (1 trial)

milk protein (1 trial)

olive oil (1 trial)

pea protein (1 trial)

salmon-polar lipids (2 trials)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Inflammation (Phase 3)

Ischemic Attack, Transient (Phase 3)

Stroke (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 16
# of Trial APIs: 18